The Chinese throat lozenges maker overcame turbulent markets to complete its Hong Kong IPO after trading in a quarter of A-share-listed companies was suspended.
Liping Zhang fills the post at the US private equity firm made vacant by Antony Leung's move to Nan Fung.
Korea's most active issuer takes advantage of a potentially temporary interval in the Greek debt drama to raise $1 billion in fresh funds.
We are pleased to announce the winners of our annual Country Awards for international banks. Day Two covers India, Indonesia, Korea, Malaysia, Pakistan and the Philippines.
A throat lozenges manufacturer, a brokerage and a private obstetrics and gynaecology hospital group are all seeking to float shares in Hong Kong.
The US private equity firm raises $241.5 million after paring stake in the Nasdaq-listed biopharmaceutical firm.
The Swiss bank's Asia Pacific private banking head Francesco de Ferrari says the bank is looking to hire amid a shortage of talent and is also staying put in Australia.
Between 30 to 40 investors participated in the share-sale of Alibaba Pictures, which plans to use the proceeds to acquire entertainment firms in China.
The Korean policy bank took advantage of a rise in Kumho’s stock price to launch the clean-up trade.
The global contractor for the offshore oil and gas industry aims to raise $300 million to deleverage its balance sheet and refinance debt.
The follow-on launched as Shanghai's stock markets fell by over 6% and was completed by offering a higher discount to the last closing price.
The US private equity firm was one of the cornerstone investors in the Chinese auto rental company's IPO last autumn.
Mark Malouf joins Credit Suisse as head of research sales in Australia after more than a decade at JP Morgan.
Accelerated placement nevertheless allows Keppel Infrastructure Trust to secure the pricing needed to fund power plant acquisition.
Investors viewed the pricing of the e-commerce company's ADRs as too dear, despite backing by backing by Alibaba and SoftBank.
Investors nonplussed by a tumble in Hong Kong's stock markets snapped up shares in the Chinese property developer.
Parent Biocon hopes the CRO's strong growth profile and expansion plans will mitigate recent downturn in the Indian equity market
Strong first quarter results encourage E-Mart and Shinsegae to pare down stakes in Samsung Life.
Taiwanese foundry company returns with its third negative yield convertible since 2009 and Asia's largest Reg S equity-linked deal in one-and-a-half years.
Keppel Infrastructure Trust launches Singapore's first major equity deal of the year, seeking up to $394 million to fund a merger and power plant acquisition.